Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Seres Therapeutics (MCRB) Q4 2024 Earnings
MCRB
6
Nov
Confirmed
Q4 2023
Q2 2024
Q3 2024
Next
-0.5
-0.36
-0.22
-0.07
Details
Expected EPS
-0.07455
Actual EPS
N/A
Surprise EPS
0.07
Surprise Percent
+100%
Description
Seres Therapeutics (MCRB) will report earnings of for Q4 2024 on November 06, 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login